Literature DB >> 12594844

The kidney as a second site of human C-reactive protein formation in vivo.

Wolfram J Jabs1, Birgit A Lögering, Peter Gerke, Burkhard Kreft, Eva-Maria Wolber, Matthias Heinrich Friedrich Klinger, Lutz Fricke, Jürgen Steinhoff.   

Abstract

C-reactive protein (CRP) is the main acute phase reactant in humans. Its production is presumably restricted to the liver but extrahepatic expression by inflamed tissue has not been studied in detail. By real-time PCR and immunohistochemistry we here show that renal cortical tubular epithelial cells (TEC) express CRP mRNA and protein within 6 h after stimulation with conditioned medium (CM) or IL-6, but not IL-1alpha or TNF-alpha. Western blot analysis with monoclonal anti-CRP antibody that recognizes native CRP revealed protein secretion into supernatants of CM-stimulated TEC cultures. While hepatoma-derived Hep3B cells could be induced similarly, peripheral blood mononuclear cells could not. CRP mRNA transcripts were observed in nephrectomized renal allografts with severe acute rejection but not with chronic allograft nephropathy (CAN). Of 19 needle biopsies of acutely rejecting kidney transplants, 15 demonstrated CRP mRNA production with the relative expression levels increasing with the severity of rejection. On the other hand, none of 7 graft biopsies with acute tubular necrosis (ATN) or CAN showed CRP mRNA expression. By using monoclonal anti-CRP antibody, cortical tubules as well as glomerular cells were shown to locally express CRP in rejecting, but not in ATN kidneys. We conclude that inflamed kidneys represent a so far unknown site of CRP formation in vivo. These data shed new light on the acute phase reaction not merely representing a systemic inflammatory pathway but probably being part of the local immune response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594844     DOI: 10.1002/immu.200390018

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  41 in total

1.  High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome.

Authors:  Anna Wasilewska; Walentyna Zoch-Zwierz; Jolanta Tobolczyk; Edyta Tenderenda
Journal:  Pediatr Nephrol       Date:  2006-11-18       Impact factor: 3.714

2.  C-reactive protein in vulnerable coronary plaques.

Authors:  Silja Norja; Lauri Nuutila; Pekka J Karhunen; Sirkka Goebeler
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

3.  C-reactive protein concentrations during bacteraemia: A comparison between patients with and without liver dysfunction.

Authors:  Iain Mackenzie; Joe Woodhouse
Journal:  Intensive Care Med       Date:  2006-06-24       Impact factor: 17.440

4.  C reactive protein and long-term risk for chronic kidney disease: a historical prospective study.

Authors:  Eitan Kugler; Eytan Cohen; Elad Goldberg; Yuval Nardi; Amos Levi; Irit Krause; Moshe Garty; Ilan Krause
Journal:  J Nephrol       Date:  2014-07-01       Impact factor: 3.902

5.  Autoantibodies against C-Reactive Protein Influence Complement Activation and Clinical Course in Lupus Nephritis.

Authors:  Qiu-Yu Li; Hai-Yun Li; Ge Fu; Feng Yu; Yi Wu; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2017-05-31       Impact factor: 10.121

6.  Is serum CRP level a reliable inflammatory marker in pediatric nephrotic syndrome?

Authors:  Eran Shostak; Irit Krause; Amit Dagan; Anat Ben-Dor; Meital Keidar; Miriam Davidovits
Journal:  Pediatr Nephrol       Date:  2016-03-08       Impact factor: 3.714

7.  C-reactive protein exacerbates renal ischemia-reperfusion injury.

Authors:  Melissa A Pegues; Mark A McCrory; Abolfazl Zarjou; Alexander J Szalai
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-27

8.  Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein.

Authors:  S P K Jagdev; W Gregory; N S Vasudev; P Harnden; S Sim; D Thompson; J Cartledge; P J Selby; R E Banks
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

9.  Urinary proteins in children with urinary tract infection.

Authors:  Lena Andersson; Iulian Preda; Mirjana Hahn-Zoric; Lars A Hanson; Ulf Jodal; Rune Sixt; Lars Barregard; Sverker Hansson
Journal:  Pediatr Nephrol       Date:  2009-04-08       Impact factor: 3.714

10.  Disease-associated glycosylated molecular variants of human C-reactive protein activate complement-mediated hemolysis of erythrocytes in tuberculosis and Indian visceral leishmaniasis.

Authors:  Waliza Ansar; Sumi Mukhopadhyay; S K Hasan Habib; Shyamasree Basu; Bibhuti Saha; Asish Kumar Sen; C N Mandal; Chitra Mandal
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.